MetXia gene therapy (Oxford BioMedica)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMetXia gene therapy (Oxford BioMedica)
Drug Alias Namemetxia基因治疗 - 牛津生物医药MetXiaP-450MetXia-MGMetXia-VM +[7] 
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transferenceCytochrome P450 modulators
TargetsCytochrome P450
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOxford Biomedica
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxford Biomedica
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A